Cargando…
Tacrolimus for the Management of Delayed Onset and Treatment-Refractory Immune-Related Hepatitis
Immune checkpoint inhibitors, such as pembrolizumab, are effective in the management of metastatic malignancies, such as melanoma, and are associated with a spectrum of immune-related organ toxicities, including immune-related hepatitis (ir-hepatitis). The clinical presentation of ir-hepatitis varie...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115544/ https://www.ncbi.nlm.nih.gov/pubmed/37091207 http://dx.doi.org/10.14309/crj.0000000000001007 |